Market Overview

Notable Questcor Pharma Call Activity

Related QCOR
BioTime CEO Explains What Could Happen To Stem Cell Research And The Company Under A New Guard In Washington
Mallinckrodt Is No Valeant-Philidor Situation, Morgan Stanley Says

Questcor October call options are seeing notable buying on the offer, even as the stock nears its low for the day.

Posted-In: Options Markets


Related Articles (QCOR)

View Comments and Join the Discussion!